Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease

Debomoy K. Lahiri, Yuan Wen Ge, Bryan Maloney, Fabienne Wavrant-De Vrièze, John Hardy

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is characterized by formation of plaques of amyloid β peptide (Aβ). Autosomally-inherited or "familial" AD had been demonstrated only in connection with coding sequence mutations. We characterized DNA-protein interaction and expression influence of two polymorphisms that occur in the promoter (C ↔ T at -3829 and T ↔ C at -1023, +1 transcription start site) of the Aβ precursor protein (APP) gene. We report distinct functional differences in reporter expression and in DNA-protein interaction for variant sequences in both -3829 and -1023 polymorphic regions. The -3829T variant has reduced DNA-protein interaction and reporter expression compared to -3829C, while -1023C has greater DNA-protein interaction and reporter expression than -1023T. Our predictions for likely transcription factors for loss of function (-3829T) are ADR1, MIG1, and PuF, and for gain of function (-1023C) are E12/E47, ITF-2, and RFX2. Characterization of the activity of a regulatory polymorphism of the APP gene points towards understanding mechanisms that likely underlie the majority of AD cases and may contribute to promoter-based drug design.

Original languageEnglish (US)
Pages (from-to)1329-1341
Number of pages13
JournalNeurobiology of Aging
Volume26
Issue number10
DOIs
StatePublished - Nov 1 2005

Fingerprint

Protein Precursors
Alzheimer Disease
Proteins
DNA
Drug Design
Transcription Initiation Site
Amyloid Plaques
Transcription Factors
Mutation

Keywords

  • Aging
  • Amyloid β protein
  • Brain
  • CAT reporter gene
  • DNA-protein interaction
  • E12/E47
  • E47
  • Gel shift assay
  • Polymorphism
  • PuF
  • Regulatory region
  • Transcription factor

ASJC Scopus subject areas

  • Clinical Neurology
  • Biological Psychiatry
  • Developmental Neuroscience
  • Neurology
  • Psychology(all)

Cite this

Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease. / Lahiri, Debomoy K.; Ge, Yuan Wen; Maloney, Bryan; Wavrant-De Vrièze, Fabienne; Hardy, John.

In: Neurobiology of Aging, Vol. 26, No. 10, 01.11.2005, p. 1329-1341.

Research output: Contribution to journalArticle

Lahiri, Debomoy K. ; Ge, Yuan Wen ; Maloney, Bryan ; Wavrant-De Vrièze, Fabienne ; Hardy, John. / Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease. In: Neurobiology of Aging. 2005 ; Vol. 26, No. 10. pp. 1329-1341.
@article{1caaf6f0d288488491fa89a484f2f219,
title = "Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease",
abstract = "Alzheimer's disease (AD) is characterized by formation of plaques of amyloid β peptide (Aβ). Autosomally-inherited or {"}familial{"} AD had been demonstrated only in connection with coding sequence mutations. We characterized DNA-protein interaction and expression influence of two polymorphisms that occur in the promoter (C ↔ T at -3829 and T ↔ C at -1023, +1 transcription start site) of the Aβ precursor protein (APP) gene. We report distinct functional differences in reporter expression and in DNA-protein interaction for variant sequences in both -3829 and -1023 polymorphic regions. The -3829T variant has reduced DNA-protein interaction and reporter expression compared to -3829C, while -1023C has greater DNA-protein interaction and reporter expression than -1023T. Our predictions for likely transcription factors for loss of function (-3829T) are ADR1, MIG1, and PuF, and for gain of function (-1023C) are E12/E47, ITF-2, and RFX2. Characterization of the activity of a regulatory polymorphism of the APP gene points towards understanding mechanisms that likely underlie the majority of AD cases and may contribute to promoter-based drug design.",
keywords = "Aging, Amyloid β protein, Brain, CAT reporter gene, DNA-protein interaction, E12/E47, E47, Gel shift assay, Polymorphism, PuF, Regulatory region, Transcription factor",
author = "Lahiri, {Debomoy K.} and Ge, {Yuan Wen} and Bryan Maloney and {Wavrant-De Vri{\`e}ze}, Fabienne and John Hardy",
year = "2005",
month = "11",
day = "1",
doi = "10.1016/j.neurobiolaging.2004.11.005",
language = "English (US)",
volume = "26",
pages = "1329--1341",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease

AU - Lahiri, Debomoy K.

AU - Ge, Yuan Wen

AU - Maloney, Bryan

AU - Wavrant-De Vrièze, Fabienne

AU - Hardy, John

PY - 2005/11/1

Y1 - 2005/11/1

N2 - Alzheimer's disease (AD) is characterized by formation of plaques of amyloid β peptide (Aβ). Autosomally-inherited or "familial" AD had been demonstrated only in connection with coding sequence mutations. We characterized DNA-protein interaction and expression influence of two polymorphisms that occur in the promoter (C ↔ T at -3829 and T ↔ C at -1023, +1 transcription start site) of the Aβ precursor protein (APP) gene. We report distinct functional differences in reporter expression and in DNA-protein interaction for variant sequences in both -3829 and -1023 polymorphic regions. The -3829T variant has reduced DNA-protein interaction and reporter expression compared to -3829C, while -1023C has greater DNA-protein interaction and reporter expression than -1023T. Our predictions for likely transcription factors for loss of function (-3829T) are ADR1, MIG1, and PuF, and for gain of function (-1023C) are E12/E47, ITF-2, and RFX2. Characterization of the activity of a regulatory polymorphism of the APP gene points towards understanding mechanisms that likely underlie the majority of AD cases and may contribute to promoter-based drug design.

AB - Alzheimer's disease (AD) is characterized by formation of plaques of amyloid β peptide (Aβ). Autosomally-inherited or "familial" AD had been demonstrated only in connection with coding sequence mutations. We characterized DNA-protein interaction and expression influence of two polymorphisms that occur in the promoter (C ↔ T at -3829 and T ↔ C at -1023, +1 transcription start site) of the Aβ precursor protein (APP) gene. We report distinct functional differences in reporter expression and in DNA-protein interaction for variant sequences in both -3829 and -1023 polymorphic regions. The -3829T variant has reduced DNA-protein interaction and reporter expression compared to -3829C, while -1023C has greater DNA-protein interaction and reporter expression than -1023T. Our predictions for likely transcription factors for loss of function (-3829T) are ADR1, MIG1, and PuF, and for gain of function (-1023C) are E12/E47, ITF-2, and RFX2. Characterization of the activity of a regulatory polymorphism of the APP gene points towards understanding mechanisms that likely underlie the majority of AD cases and may contribute to promoter-based drug design.

KW - Aging

KW - Amyloid β protein

KW - Brain

KW - CAT reporter gene

KW - DNA-protein interaction

KW - E12/E47

KW - E47

KW - Gel shift assay

KW - Polymorphism

KW - PuF

KW - Regulatory region

KW - Transcription factor

UR - http://www.scopus.com/inward/record.url?scp=26944436685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26944436685&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2004.11.005

DO - 10.1016/j.neurobiolaging.2004.11.005

M3 - Article

C2 - 16243604

AN - SCOPUS:26944436685

VL - 26

SP - 1329

EP - 1341

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 10

ER -